Telix Pharmaceuticals Ltd (TLX)
$11.27-$0.09 (-0.75%) Today
Latest TLX Insider Trades
Christian Behrenbruch - OfficerOpen-market purchase$500K
Christian Behrenbruch - Officer
Darren Charlton Smith - OfficerDarren Charlton Smith - OfficerTelix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
No Form 4 activity for TLX in the last 90 days.
2 Form 4 filings on record, the earliest from Apr 1, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Christian Behrenbruch - Officer | Open-market purchase | Ordinary Shares | 34,500 | $14.48 | $500K | |
| Christian Behrenbruch - Officer | Open-market purchase | Ordinary Shares | 33,435 | $14.87 | $497K | |
| Darren Charlton Smith - Officer | Option exercise | Ordinary Shares | 1,111 | $0.00 | - | |
| Darren Charlton Smith - Officer | Option exercise | Share Rights | 1,111 | $0.00 | - |
Telix Pharmaceuticals Ltd (TLX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-07. The full record for TLX runs to 2 Form 4 filings, the earliest from 2026-04-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of TLX were filed in the last 90 days. 2 purchases are on record for this company.
No insider sales of TLX were filed in the last 90 days.
This page tracks TLX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add TLX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
